ADVANCED
Published: 15:29, November 25, 2020 | Updated: 10:10, June 5, 2023
Sinopharm applies for vaccine market approval
By chinadaily.com.cn
A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020. (ZHANG YUWEI / XINHUA)
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.
ALSO READ: Trials for 2 Sinopharm COVID-19 vaccines progress
ALSO READ
More
China calls for UN-led international probe of Nord Stream blasts
Mutual progress key for relationship, Xi tells Blinken
Chinese premier chairs State Council executive meeting
Xi exchanges congratulations with Tanzanian president over 60th anniversary of ties
Xi: China hopes US can view its development positively
May Day holiday: Travel to and from China expected to rise
Embassy: Chinese scuba diver drowns in central Philippines
China's top legislature concludes standing committee session
Columns
COMPANY
Download
Copyright 1995 - 2024. All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily. Without written authorization from China Daily, such content shall not be republished or used in any form.